logo

Vertex Pharmaceuticals Inc. (VRTX)



Trade VRTX now with
  Date
  Headline
4/26/2018 4:12:48 PM Vertex Pharmaceuticals Q1 EPS $0.81 Vs. $0.99 Year Ago
4/6/2018 8:46:36 AM Jefferies Is Raising Vertex Pharmaceuticals Inc. (VRTX) 2019 Estimate To 4.04 From 3.75
4/6/2018 8:46:20 AM Jefferies Is Increasing Vertex Pharmaceuticals Inc. (VRTX) 2018 Estimate To 3.02 From 2.76
4/4/2018 8:03:23 AM Q-State Biosciences And Vertex Pharma Enter Into Multi-Year Drug Discovery Collaboration
3/29/2018 2:19:52 PM Vertex Appoints Kimberly White As SVP And Chief Communications Officer
3/5/2018 9:22:13 AM New Drugs Approved In February
3/1/2018 7:31:59 AM Vertex Initiates Phase 3 Study Of VX-659, Tezacaftor And Ivacaftor As A Triple Combination Regimen
2/26/2018 9:18:43 AM Vertex : Chief Medical Officer Jeffrey Chodakewitz To Retire And Serve As Senior Advisor Through Early 2019
2/26/2018 9:17:12 AM Vertex Appoints Reshma Kewalramani As Chief Medical Officer And EVP, Global Medicines Development And Medical Affairs
2/14/2018 8:36:12 AM Vertex Reports Treatment With NaV1.8 Inhibitor VX-150 Showed Significant Relief Of Acute Pain In Phase 2 Study
2/12/2018 4:53:04 PM Vertex: FDA OKs SYMDEKOTM For Underlying Cause Of Cystic Fibrosis In People Ages 12, Older With Mutations In CFTR Gene
2/1/2018 12:12:43 AM Vertex Selects VX-659 & VX-445 To Advance Into Phase 3 Development As Part Of Two Different Triple Combination Regimens
1/31/2018 4:06:16 PM Vertex Pharma Q4 Non-GAAP EPS $0.61 Vs $0.35 Last Year